Skip to content
Sign in

MEDP · NASDAQ

Medpace Holdings (MEDP) Stock Price & Fundamentals

$329.65+0.63%+$2.08End-of-day price as of Oct 9, 2026

Medpace Holdings (MEDP) closed at $329.65 on Oct 9, 2026, up 0.63% from the previous close of $327.57.

Share price, past year

1Y +1.09%

52-week range $300.90 – $364.69. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$329.65
Sep 30, 2026$324.14
Aug 31, 2026$336.39
Jul 31, 2026$354.47
Jun 30, 2026$357.28
May 29, 2026$340.39
Apr 30, 2026$337.33
Mar 31, 2026$328.68
Feb 27, 2026$333.25
Jan 30, 2026$339.54
Dec 31, 2025$347.54
Nov 28, 2025$333.34
Oct 31, 2025$306.82

Key statistics

Market cap
$9.20B
P/E (TTM)
19.4
EPS (TTM)
$17.04
Revenue (TTM)
$2.78B
Net income (TTM)
$491.50M
Shares outstanding
27.9M
Dividend yield
—
52-week range
$300.90 – $364.69

Medpace Holdings's market cap is $9.20B, based on a share price of $329.65 and 27.9M shares outstanding as of Jun 30, 2026.

Financials

Medpace Holdings reported revenue of $2.53B for fiscal 2025, up 19.97% from fiscal 2024.

Medpace Holdings earned net income of $451.12M in fiscal 2025, a net margin of 17.8%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Medpace Holdings annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$2.53B+20.0%$451.12M17.8%$15.28$681.87M
FY2024ended Dec 31, 2024$2.11B+11.8%$404.39M19.2%$12.63$572.27M
FY2023ended Dec 31, 2023$1.89B+29.2%$282.81M15.0%$8.88$396.73M
FY2022ended Dec 31, 2022$1.46B+27.8%$245.37M16.8%$7.28$351.17M
FY2021ended Dec 31, 2021$1.14B+23.4%$181.85M15.9%$4.81$235.06M
FY2020ended Dec 31, 2020$925.93M+7.5%$145.38M15.7%$3.84$227.34M
FY2019ended Dec 31, 2019$860.97M+22.2%$100.44M11.7%$2.67$183.96M
FY2018ended Dec 31, 2018$704.59M+61.6%$73.19M10.4%$1.97$140.56M
FY2017ended Dec 31, 2017$436.15M+3.5%$39.12M9.0%$0.98$85.66M
FY2016ended Dec 31, 2016$421.58M—$13.43M3.2%$0.37$78.20M
Medpace Holdings quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$707.33M$121.36M$4.25
Q1 FY2026ended Mar 31, 2026$706.60M$123.87M$4.28
Q4 FY2025ended Dec 31, 2025$708.45M$135.13M$4.65
Q3 FY2025ended Sep 30, 2025$659.90M$111.14M$3.86
Q2 FY2025ended Jun 30, 2025$603.31M$90.26M$3.10
Q1 FY2025ended Mar 31, 2025$558.57M$114.60M$3.67
Q4 FY2024ended Dec 31, 2024$536.59M$117.02M$3.67
Q3 FY2024ended Sep 30, 2024$533.32M$96.43M$3.01

Company profile

Name
Medpace Holdings, Inc.
Ticker
MEDP
Exchange
NASDAQ
Industry (SEC SIC)
Services-Commercial Physical & Biological Research
Headquarters
5375 Medpace Way, Cincinnati, OH 45227
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001668397

Recent SEC filings

Frequently asked questions

What is Medpace Holdings's stock price?

Medpace Holdings (MEDP) closed at $329.65 on Oct 9, 2026, up 0.63% from the previous close of $327.57.

What is Medpace Holdings's market cap?

Medpace Holdings's market cap is $9.20B, based on a share price of $329.65 and 27.9M shares outstanding as of Jun 30, 2026.

How much revenue does Medpace Holdings make?

Medpace Holdings reported revenue of $2.53B for fiscal 2025, up 19.97% from fiscal 2024.

What is MEDP's P/E ratio?

Medpace Holdings's price-to-earnings ratio is 19.4, based on trailing twelve-month diluted EPS of $17.04.

Does Medpace Holdings pay a dividend?

Medpace Holdings's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Medpace Holdings, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures